D. Hurley

发表

Real-world costs of ischemic stroke by discharge status

E. Wu, K. Betts, F. Mu, 2016, Current Medical Research and Opinion.

Erythropoietin stimulating agent dose and use patterns in cancer patients

W. Grochulski, V. Willey, J. Whyte, 2007 .

PCN34 ANALYSIS OF DOSE, COST AND USE PATTERNS OF ERYTHROPOIETIN STIMULATING AGENTS IN CANCER PATIENTS

W. Grochulski, V. Willey, J. Whyte, 2007 .

Does Emergency Medical Services Transportation Mitigate Post-stroke Discharge Disability? A Prospective Observational Study

J. Hardin, S. Xirasagar, S. Sen, 2020, Journal of General Internal Medicine.

Use and cost of erythropoiesis-stimulating agents in patients with cancer

Marcus D. Wilson, V. Willey, J. Whyte, 2009, Current medical research and opinion.

Impact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy

K. Ruiz, D. Hurley, Xue Song, 2009, Journal of medical economics.

A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).

M. Regan, D. McDermott, R. Joyce, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

A Retrospective, Longitudinal, Claims-Based Comparison of Concomitant Diagnoses Between Individuals with and Without Down Syndrome.

D. Brixner, J. Visootsak, D. Hurley, 2017, Journal of managed care & specialty pharmacy.

To Treat or Not to Treat?: Exploring Factors Influencing Intravenous Thrombolysis Treatment Decisions for Minor Stroke

J. Grotta, S. Kasner, J. Broderick, 2018, Stroke.

Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer

P. Richardson, D. Kufe, D. McDermott, 2000, Bone Marrow Transplantation.

The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis

A. Farr, D. Hurley, S. Curkendall, 2016, Journal of medical economics.

Polymicrobial cholangitis and Kaposi's sarcoma in blood product transfusion-related acquired immune deficiency syndrome.

N. LaRusso, P. Banks, J. Katzmann, 1986, The American journal of medicine.

Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.

Jinlin Song, E. Wu, K. Betts, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Why acute ischemic stroke patients in the United States use or do not use emergency medical services transport? Findings of an inpatient survey

J. Hardin, S. Xirasagar, S. Sen, 2019, BMC health services research.

Impact of primary prophylaxis on febrile neutropenia within community practices in the US

V. Morrison, D. Hershman, J. Malin, 2009, Journal of medical economics.

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study

K. Tomic, J. Malin, D. Hurley, 2011, Current medical research and opinion.

Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.

M. Regan, D. McDermott, R. Joyce, 2001, European journal of haematology. Supplementum.

Real-world costs of ischemic stroke by discharge status

D. Hurley, M. Paschoalin, F. Mu, 2017, Current medical research and opinion.